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Polyhedral erythrocytes, named polyhedrocytes, are formed in contracted blood clots and thrombi, as 
a result of compression by activated contractile platelets pulling on fibrin. This deformation was shown 
to be mechanical in nature and polyhedrocytes were characterized using light and electron microscopy. 
Through three-dimensional reconstruction, we quantified the geometry of biconcave, intermediate, 
and polyhedral erythrocytes within contracting blood clots. During compression, erythrocytes became 
less oblate and more prolate than the biconcave cells and largely corresponded to convex, irregular 
polyhedra with a total number of faces ranging from 10 to 16. Faces were polygons with 3 to 6 sides. 
The majority of the faces were quadrilaterals, though not all sides were straight and not all faces were 
flat. There were no changes in the surface area or volume. These results describe the gradual natural 
deformation of erythrocytes as a part of compaction into a tightly packed array that is an important but 
understudied component of mature blood clots and thrombi.
Erythrocytes were commonly believed to be passive bystanders in the processes involved in blood clotting, but 
recent studies revealed that they play a more influential role in both hemostasis and thrombosis1,2. Besides their 
indirect rheological effects, including marginalization of platelets in the blood flow, erythrocytes have the ability 
to directly modulate thrombin generation, fibrin formation, structure3,4, and the viscoelastic properties of the 
clot3,5,6. In particular, the incorporation of erythrocytes into the clot has been shown to determine the clot size7 
and result in a hematocrit-dependent reduced extent of clot contraction (aka clot retraction)5. Clot contraction, 
or the volume shrinkage of the clot, occurs when activated platelets pull on the fibrin network8,9. This results in 
the compaction of erythrocytes to the core of the clots and redistribution of platelets and fibrin toward the outside 
of the clot10. The erythrocytes amassed in the core of the contracting clot undergo a shape transformation from 
their native biconcave shape to that of polyhedra, hence named polyhedrocytes10. The presence of polyhedrocytes 
in the core of the clot reduce clot permeability and consequently are thought to play a role in hemostasis10. The 
reduced extent of clot contraction, implying a larger volume and a less compact structure, may aggravate arterial 
and venous thrombosis due to increased obstructiveness and perhaps propensity of a thrombus to rupture and 
embolize11,12.
This remarkable polyhedral shape of erythrocytes, first described by Gottlob et al.13 and rediscovered 
later10,12,14,15, is a natural morphological form of erythrocytes in addition to echinocytes, acanthocytes, spheroe-
chinocytes, ovalocytes, elliptocytes, stomatocytes, and more16. From a more general perspective, polyhedra have 
been observed in nature17 and in non-biological materials18,19 since before the time of Plato in a variety of plant 
and animal cells, viruses, tissues, foams and metals20. It has been shown that some polyhedral shapes allow for 
the minimization of interface area between cells21, the minimization of potential energy in the system17, and the 
stabilization of the membrane skeleton22. It is biologically important that polyhedrocytes are able to minimize 
the space between cells, due to more efficient packing, which helps to create an impermeable seal at the site of 
vessel injury to prevent bleeding10,23. Polyhedrocytes formed intravitally have been observed in clots and thrombi 
obtained from human and murine samples10,12,23–25.
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